Back to top

Latest News

9 March 2015

Dance For Health

A new health and fitness opportunity for those with multiple sclerosis is about to hit Sydney.

Dance For Health is inviting people with multiple sclerosis to join a complementary open movement class. It will be held on Friday 10 April at Sydney Dance Company.

Dance For Health...

25 February 2015

Injectable MS medication Plegridy to be listed on the PBS

Biogen Idec has announced that their new injectable medication PLEGRIDY  (peginterferon beta-1a) will be listed on the Pharmaceutical Benefits Scheme (PBS) for treatment of patients with relapsing-remitting multiple sclerosis from March 1.

Plegridy is a sub-cutaneous injection treatment...

2 February 2015

Oceans of Hope to visit Australia

MS Australia is delighted to announce that the hugely popular Sailing Sclerosis ‘Oceans of Hope vessel and team will be heading to Australia this May.
 
Oceans of Hope is a 67ft ocean yacht currently completing an...

Genetic DNA
22 January 2015

New biomarkers to predict progression in MS

While the primary and secondary progressive forms of multiple sclerosis (PPMS and SPMS) have different pathological characteristics, scientists do not know if they share common neurodegenerative mechanisms.

The authors of a recent paper in the Journal of Neurology measured cerebrospinal...

doctor talking to patient
1 January 2015

MS Australia welcomes Minister Ley's common sense decision

MS Australia, the national peak body advocating on behalf of people affected by multiple sclerosis, today commended Federal Health Minister Sussan Ley for scrapping planned reductions to the Medicare rebate.

MS Australia Chief Executive Debra Cerasa said Minister Ley has clearly signalled...

doctor talking to patient
1 January 2015

MS Australia welcomes Minister Ley's common sense decision

MS Australia, the national peak body advocating on behalf of people affected by multiple sclerosis, today commended Federal Health Minister Sussan Ley for scrapping planned reductions to the Medicare rebate.

MS Australia Chief Executive Debra Cerasa said Minister Ley has clearly signalled...

blood pressure test
10 December 2014

Federal Government must protect people living with MS

MS Australia has called on the Federal Government to protect people living with multiple sclerosis (MS) and other lifelong conditions as part of new regulations being drafted to incorporate changes to the co-payment proposal.

MS Australia Chief Executive Officer Debra Cerasa said there is...

sunshine through trees
9 December 2014

Subsidised Vitamin D tests still available for people with MS

A recent review of vitamin D testing conducted by the Medicare Services Advisory Committee (MSAC) has recommended tighter regulations around the availability of vitamin D testing.

The aim of the review was to identify people at high-risk of conditions and diseases related to low vitamin D...

couple receiving award
14 November 2014

Mount Colah couple awarded highest MS Australia accolade

Two dedicated fundraisers and advocates have been formally recognised for their years of commitment to helping those in the multiple sclerosis (MS) community.

Mike and Katrina Hemingway, founding members of Foundation 5 Million have been awarded the 2014 John Studdy Award, MS...

advocates outside parliament house
5 November 2014

MS National Advocates Conference 2014

From 27-29 October, MS Australia held its annual National Advocates Conference in Canberra. All 12 Advocates from across Australia came together for the two day event to discuss key priorities for people with multiple sclerosis and to meet with key policy makers to profile issues currently...

bottle of medication
24 October 2014

European patient shows signs of PML

The pharmaceutical sponsor of Tecfidera, Biogen Idec, has this week notified neurologists of one case of Progressive multifocal leukoencephalopathy (PML) in an individual currently being treated with Tecfidera in Europe.

Thousands of people with MS around the world are currently treated...

bottle of medication
17 September 2014

Pharmaceutical Benefits Advisory Committee November Meeting

This November the Pharmaceutical Benefits Advisory Committee (PBAC) will consider two new MS treatments for subsidisation.

The first, Lemtrada is a Therapeutics Goods Administration (TGA) approved treatment that has previously received PBAC approval but requires resubmission to finalise...

Pages